WWW.JNEUROSCI.ORG
-
Life science instruments for behavioral neuroscience research
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lhuillier, L.
Right arrow Articles by Dryer, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lhuillier, L.
Right arrow Articles by Dryer, S. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 2000, 20(15):5616-5622

Developmental Regulation of Neuronal KCa Channels by TGFbeta 1: Transcriptional and Posttranscriptional Effects Mediated by Erk MAP Kinase

Loic Lhuillier and Stuart E. Dryer

Department of Biology and Biochemistry, University of Houston, Houston, Texas 77204-5513


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

An avian ortholog of transforming growth factor beta 1 (TGFbeta 1) is the target-derived factor responsible for the developmental expression of large-conductance Ca2+-activated K+ (KCa) channels in chick ciliary ganglion (CG) neurons developing in vivo and in vitro. Application of TGFbeta 1 evokes an acute stimulation of KCa that can be observed immediately after cessation of a 12 hr exposure to this factor, that persists in the presence of protein synthesis inhibitors, and that is therefore mediated by posttranslational events. Here we show that a single 3 hr exposure to TGFbeta 1 can also induce long-lasting stimulation of macroscopic KCa that persists for at least 3.5 d after the end of the treatment. In contrast to the acute stimulation, this sustained effect is dependent on the transcription and synthesis of new proteins at approximately the time of TGFbeta 1 treatment. However TGFbeta 1 does not cause increases in the levels of slowpoke alpha  subunit transcripts in CG neurons, suggesting that induction of some other protein or proteins is required for sustained enhancement of macroscopic KCa. In addition, application of TGFbeta 1 evoked an almost immediate but transient phosphorylation of the mitogen-activated protein kinase Erk in CG neurons. TGFbeta 1-evoked Erk activation was blocked by the specific MEK1 inhibitor 2- (2'-amino-3'-methoxyphenyl)-oxanaphthalen-4-one (PD98059). Moreover, application of PD98059 blocked both acute and sustained KCa stimulation evoked by TGFbeta 1. These results indicate that TGFbeta 1 elicits a biphasic stimulation of KCa via activation of an MEK1-Erk pathway and raise the possibility that other neuronal effects of TGFbeta superfamily members entail Erk activation.

Key words: TGFbeta ; slowpoke; trophic factor; MAP kinase; neuregulin; ciliary ganglion


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The functional expression of Ca2+-activated K+ channels (KCa) in the large neurons of the developing chick ciliary ganglion (CG) requires interactions with target tissues in the eye (Dourado et al., 1994; Dryer, 1998). This effect is mediated by a soluble trophic factor expressed in the iris, one of the main target tissues of CG neurons (Subramony et al., 1996). We have presented evidence recently indicating that this iris-derived factor is an isoform of transforming growth factor beta  (TGFbeta ) (Cameron et al., 1998, 1999; Lhuillier and Dryer, 1999). Transcripts encoding TGFbeta 4, the principal avian ortholog of TGFbeta 1 (Burt and Paton, 1992), are expressed in the iris at the appropriate developmental stages (Cameron et al., 1999), and application of recombinant TGFbeta 1 to CG neurons developing in vitro or in vivo stimulates the functional expression of KCa. Moreover, intraocular injection of a neutralizing pan-TGFbeta antiserum inhibits the normal expression of KCa in CG neurons developing in vivo, and the same antiserum blocks the effects of iris extracts on CG neurons developing in vitro (Cameron et al., 1998).

Our previous studies have shown that significant stimulation of KCa in CG neurons is not detectable until at least 5 hr after the onset of a continuous exposure to TGFbeta 1. In spite of this relatively slow time course, the stimulatory effects of TGFbeta 1 are not affected by protein synthesis inhibitors and therefore appear to be posttranslational (Subramony et al., 1996; Cameron et al., 1998). These observations raise several questions. For example, it is not known whether the stimulatory effects of TGFbeta 1 are persistent or, alternatively, whether this factor needs to be present continuously to maintain high densities of functional KCa channels. In addition, the nature of the transduction cascades that mediate the actions of TGFbeta 1 is unknown.

This last question is of interest because the actions of TGFbeta s in many systems are caused by SMAD-dependent changes in transcriptional regulation. SMADs are transcription factors that are phosphorylated after stimulation of TGFbeta receptors and translocated to the nucleus as heteromeric complexes resulting in changes in gene expression (for review, see Baker and Harland, 1997; Heldin et al., 1997; Massague, 1998). These pathways do not provide an obvious explanation for the posttranslational effects of TGFbeta 1 on KCa expression in CG neurons. However, a number of reports indicate that TGFbeta s can also cause activation of mitogen-activated protein kinase (MAP kinase) cascades within minutes after the onset of TGFbeta treatment (Hartsough and Mulder, 1995; Hartsough et al., 1996).

We now report that KCa stimulation evoked by a single 3 hr application of TGFbeta 1 can be observed for almost 4 d after cessation of treatment. The mechanism of this sustained effect differs from the acute stimulation of KCa in that it requires both transcription and translation as well as a longer duration of TGFbeta 1 treatment. We also show that TGFbeta 1 evokes a transient activation of the MAP kinase Erk in CG neurons and that Erk activation is essential for both the acute and sustained effects of TGFbeta 1 on KCa expression.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell isolation and culture. Ciliary ganglion neurons were dissociated at embryonic day 9 (E9) or E13 as described previously (Subramony et al., 1996; Cameron et al., 1998, 1999; Lhuillier and Dryer, 1999). Experiments on acutely dissociated E13 cells were performed within 3 hr of cell dissociation. Neurons dissociated at E9 were grown for various lengths of time, as indicated in the text and figure legends, on poly-D-lysine-coated glass coverslips in a culture medium described previously (Subramony et al., 1996; Cameron et al., 1998, 1999). Recombinant human TGFbeta 1 was obtained from R & D Systems (Minneapolis, MN). For experiments designed to examine the role of protein synthesis in the regulation of KCa, the reversible translational inhibitor anisomycin (0.1 mg/ml) and the reversible transcriptional inhibitor 5,6-dichlorobenzimidazole riboside (DRB; 100 µM) were obtained from Sigma (St. Louis, MO) and added to culture media immediately before use. These agents have been shown previously to cause essentially complete inhibition of protein (Subramony et al., 1996) and RNA (Bruses and Pilar, 1995) synthesis in cultured CG neurons. The MEK1 inhibitor 2-(2'-amino-3'-methoxyphenyl)-oxanaphthalen-4-one (PD98059) and the Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) inhibitor KN-62 were obtained from Sigma. Cells were incubated with these inhibitors 30 min before the addition of trophic factors.

Electrophysiology. Whole-cell recordings were made using standard methods as described previously (Dourado and Dryer, 1992; Dourado et al., 1994; Subramony et al., 1996; Cameron et al., 1998, 1999). Briefly, 25 msec depolarizing steps to 0 mV were applied from a holding potential of -40 mV in normal and nominally Ca2+-free salines containing 500 nM tetrodotoxin, and the net Ca2+-dependent currents were obtained by digital subtraction using Pclamp software (Axon Instruments, Foster City, CA). Currents were normalized for cell size by computing the soma surface area as described previously (Dourado and Dryer, 1992; Subramony et al., 1996; Cameron et al., 1998, 1999). Similar protocols were used to analyze voltage-activated Ca2+ currents except that KCl in the recording pipettes was replaced with CsCl as described previously (Dourado and Dryer, 1992; Dourado et al., 1994; Cameron et al., 1999). Throughout this paper, error bars represent SEM. Data were analyzed by one-way ANOVA followed by Scheffé's multiple range test using Statistica software (Statsoft, Tulsa, OK), with p < 0.05 regarded as significant.

Immunoblot analysis of mitogen-activated protein kinase (Erk) phosphorylation. For each experimental group, a total of 10 E9 CG were plated onto a single coverslip. TGFbeta 1 (1 nM) was applied to cultures 3 hr after plating and maintained for varying lengths of time as indicated. Controls did not receive trophic factors. Cells were then washed in ice-cold PBS and lysed in 2× Laemmli sample buffer. Samples were boiled for 5 min and separated by SDS-PAGE on 12% gels. Proteins were transferred to nitrocellulose membranes, which were then blocked in a Tris-buffered saline containing 0.1% Tween 20 and 5% nonfat dried milk before overnight incubation with either a monoclonal antibody specific for diphospho-Erk (Erk-P2; Sigma) or a polyclonal antibody insensitive to the phosphorylation state of Erk (Santa Cruz Biochemicals). Each sample was probed with both antibodies. Blots were analyzed using anti-mouse and anti-rabbit secondary antibodies conjugated to horseradish peroxidase and an ECL detection system (Amersham, Arlington Heights, IL). The ratio of Erk-P2 to total Erk in each culture was determined by densitometry using Scion Image software (Scion Corporation, Frederick, MD). All experiments were repeated three to six times.

Reverse transcription-PCR analysis of slo transcript expression. The alpha  subunits of large-conductance KCa channels are encoded by the slowpoke (slo) gene. Reverse transcription (RT)-PCR procedures for detection of slo transcripts in chick CG are modified from the methods of Subramony et al. (1996). CG neurons were dissociated at E9, plated at a density of two ganglion equivalents per glass coverslip, and exposed to 1 nM TGFbeta 1 3 hr after isolation. Control preparations did not receive TGFbeta 1. Total RNA was isolated from each coverslip using a commercial version of the method of Chomczynski and Sacchi (1987) (Genosys, Woodlands, TX). All of the extracted RNA was random transcribed (1 hr at 37°; Pro-Star RT-PCR kit; Stratagene, La Jolla, CA). All quantitative procedures were performed using the same lot of reverse transcriptase. For PCR analysis of beta -actin and slo, cDNAs were amplified in separate tubes using 5 µl of the first-strand product with the following primers: for slo, 5'-GAA-TAC-CTG-AGA-AGG-GAA-TGG-GAG-3' (forward) and 5'-ATG-CGG-GTC-CAC-ATG-CAA-AG-3' (reverse) as described previously (Subramony et al., 1996), and for beta -actin, 5'-TGC-TGT-GTT-CCC-ATC-TAT-CGT-G-3' (forward) and 5'-TCT-TTC-TGG-CCC-ATA-CCA-ACC-3' (reverse). The beta -actin primers yield a 68 bp product whose identity was confirmed by sequencing using methods described previously (Subramony et al., 1996). PCR reactions were performed in 20 µl of a buffer consisting of 2.5 mM MgCl2, 60 mM Tris, 15 mM (NH4)3SO4, 0.25 mM each dNTP, 150 pmol of each primer, and 1 U of Taq polymerase (Promega, Madison, WI). Cycling parameters were 2 min at 92° followed by 25 cycles (slo) or 20 cycles (beta -actin) of 1 min at 92°, 3 min at 57°, and 3 min at 72°, followed by a 10 min extension at 72°. These parameters were optimized to remain on the linear phase of the amplification curves for both slo and beta -actin. PCR products were separated on 1.5% agarose gels containing ethidium bromide, and band intensity was quantified by densitometry using Scion Image software. To establish that the RT-PCR procedures were quantitative, total RNA was extracted from E9 CG neurons and subjected to serial dilution. For both beta -actin and slo, the amount of RT-PCR product was linearly related to the initial total RNA concentration. Quantitation of the effects of TGFbeta 1 was performed by two different procedures. First, we determined the amount of slo and beta -actin PCR product produced by amplifying from a fixed concentration of total cDNA. Data obtained from this experimental design are expressed as slo beta -actin ratios to normalize for possible differences in the efficiency of RNA extraction, gel loading, etc. Second, total cDNAs obtained from control and TGFbeta 1-treated cells were subjected to serial dilution to determine the minimum cDNA concentration required to yield a detectable slo PCR product (Tkatch et al., 2000). In these experiments, the cDNA from control and TGFbeta 1-treated cells had indistinguishable levels of beta -actin transcript expression.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Acute and sustained effects of TGFbeta 1 on KCa expression in CG neurons

These experiments were performed on CG neurons dissociated at E9. Application of 1 nM recombinant human TGFbeta 1 for 12 hr caused a robust increase in the functional expression of macroscopic KCa compared with that in controls cultured in the absence of trophic factors (Fig. 1). This increase, which was apparent at the end of the 12 hr treatment (acute stimulation), persisted for at least 3.5 d after the cessation of treatment (sustained stimulation; Fig. 1B,C). The acute and sustained effects of TGFbeta 1 differ in two important ways. First, the acute effect of TGFbeta 1 could be evoked in the presence of either the reversible transcriptional inhibitor DRB (100 µM) or the reversible translational inhibitor anisomycin (0.1 mg/ml). This indicates that posttranslational mechanisms are sufficient for acute KCa stimulation in CG neurons, as noted in previous reports from our laboratory (Subramony et al., 1996; Cameron et al., 1998). By contrast, the sustained increase in KCa expression was blocked when either anisomycin (Fig. 1C) or DRB (Fig. 1D) were present during and up to 12 hr after cessation of TGFbeta 1 treatment. These results are statistically significant (p < 0.05). An identical pattern was observed when KCa expression was stimulated with iris extracts (data not shown). Therefore, the KCa stimulatory action of TGFbeta 1 in CG neurons is biphasic and has an acute posttranslational component and a sustained component dependent on transcriptional activation and the synthesis of new proteins during or up to12 hr after TGFbeta 1 treatment. Inhibition of protein synthesis in this manner had no effect on the expression of voltage-activated Ca2+ currents at either time point after TGFbeta 1 treatment (data not shown). Second, the acute and sustained components of KCa stimulation require different durations of TGFbeta 1 treatment (Fig. 2). This was established by an experimental design in which 1 nM TGFbeta 1 was applied to E9 CG neurons for different lengths of time, ranging from 5 min to 12 hr. TGFbeta 1 was then removed, and CG neurons were maintained in normal medium until either 12 hr or 4 d after the onset of TGFbeta 1 treatment. Maximal acute stimulation of KCa expression (measured at 12 hr) was achieved with a 1 hr exposure to 1 nM TGFbeta 1. In contrast, maximum sustained KCa expression (measured at 4 d) required 3 hr of exposure to 1 nM TGFbeta 1 and was significantly (p < 0.05) less than maximal with 1 hr of TGFbeta 1 treatment (Fig. 2).



View larger version (13K):
[in this window]
[in a new window]
 
Figure 1.   The acute and sustained effects of TGFbeta 1 on KCa expression are differentially sensitive to inhibition of protein synthesis. A, Schematic diagram of experimental design. E9 CG neurons were cultured for 12 hr in the presence of 1 nM TGFbeta 1, in the presence of 1 nM TGFbeta 1 and protein synthesis inhibitors, or in the absence of any trophic factor. KCa expression was quantified by whole-cell recording immediately or 3.5 d after the cessation of TGFbeta 1 treatment, as indicated by arrows. B, Representative traces of macroscopic KCa currents in E9 CG neurons treated as indicated. C, Summary of the effects of the reversible translational inhibitor anisomycin in many cells. A single 12 hr application of TGFbeta 1 evoked a robust and significant (p < 0.05) stimulation of KCa () compared with that in control cells (open circle ). A significant (p < 0.05) acute stimulation of KCa persisted in the presence of anisomycin (0.1 mg/ml; black-square). This increase in whole-cell currents is long lasting and can be seen 3.5 d after the end of the TGFbeta 1 treatment. However, this sustained effect is blocked by treatment with anisomycin during the first 24 hr (p < 0.05). D, Similar results obtained with the reversible transcriptional inhibitor DRB (100 µM; black-square). Therefore transcriptional and translational events during the first 24 hr after the onset of TGFbeta 1 treatment are necessary to produce a long-lasting stimulation of macroscopic KCa. Data are the mean ± SEM computed from 7 to 15 cells in each group. Data were analyzed by one-way ANOVA followed by Scheffé's post hoc test.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 2.   Sustained stimulation of KCa requires a longer duration of TGFbeta 1 exposure than does acute stimulation. E9 CG neurons were cultured in the presence of 1 nM TGFbeta 1 for the times indicated on the x-axis. The medium was then changed, and whole-cell KCa was measured 12 hr (open circle ) or 4 d () after the start of TGFbeta 1 treatment. Currents are normalized to the maximum for each group. Note that a single 1 hr exposure to TGFbeta 1 is sufficient to produce maximal acute KCa stimulation. However a 3 hr treatment with TGFbeta 1 is needed to produce maximal long-lasting KCa expression. Data are the mean ± SEM computed from 8 to 21 cells for each point.

Although sustained stimulation of KCa expression in CG neurons requires the transcription and synthesis of new proteins at approximately the time of TGFbeta 1 application, the experiments with DRB and anisomycin do not indicate whether it is the SLO alpha  subunits themselves that are induced. For example, TGFbeta 1 actions on the functional expression of KCa channels could entail induction of other proteins, e.g., auxiliary subunits or proteins required for plasma membrane insertion. To test this hypothesis, the effects of TGFbeta 1 on the expression of slo transcripts were analyzed using semiquantitative RT-PCR procedures (Fig. 3). In initial experiments, we established RT-PCR procedures that could detect small differences in the amounts of beta -actin and slo transcripts present in a complex mixture of total RNA and that yielded a linear relationship between starting transcript levels and the yield of final products. To test the hypothesis, E9 CG neurons were cultured for 12 hr in the presence or absence of 1 nM TGFbeta 1, total RNA was extracted, and slo and beta -actin transcript expressions were determined. By the use of a fixed cDNA template concentration, treatment with TGFbeta 1 had no effect on the slo/beta -actin transcript ratio (Fig. 3A). Moreover, by the use of a range of total cDNA template dilutions, TGFbeta 1 treatment had no effect on the minimum cDNA concentration required to yield a visible slo PCR product (Fig. 3B). In other words, we find no evidence of the induction of slo alpha  subunit transcripts by TGFbeta 1. Instead, these data suggest that the sustained effects of TGFbeta 1 on the functional expression of KCa channels are associated with new synthesis of some other protein or proteins.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3.   TGFbeta 1 does not stimulate an increase of slo transcript levels in CG neurons. E9 CG neurons were treated with 1 nM TGFbeta 1 for 12 hr at which time slo expression was determined by semiquantitative RT-PCR. A, Top, Examples of slo and beta -actin transcript detection by RT-PCR in control and TGFbeta 1-treated cells are shown. Note the comparable intensity signals for both transcripts in both groups of cells. Bottom, The mean ± SEM of the slo/beta -actin intensity ratios derived from six repetitions of this experiment is shown and indicates that TGFbeta 1 has no significant effect on slo expression in CG neurons. B, To confirm this result, cDNA from the same cultures used in A was subjected to serial dilution before PCR. Top, Results of a representative serial dilution experiment are shown. Bottom, The mean ± SEM of the log10 of the maximal dilution at which slo transcripts could be detected is shown. Data are derived from six repetitions of this experiment. This value is not increased in TGFbeta 1-treated cells, further indicating that TGFbeta 1 does not increase slo transcript expression.

Role of mitogen-activated protein kinase cascades in TGFbeta 1 actions

The fact that acute stimulation of KCa channels by TGFbeta 1 occurs by posttranslational mechanisms in CG neurons raises an important question as to the nature of the underlying transduction cascade. SMAD activation seems unlikely, because these proteins are transcription factors that have distinct trans-activation and protein interaction domains but that lack motifs that would suggest other enzymatic activities (Kretzschmar and Massague, 1998; Shioda et al., 1998; Johnson et al., 1999). However, there are reports of rapid activation of MAP kinases by TGFbeta 1 in non-neuronal systems (Hartsough and Mulder, 1995; Hartsough et al., 1996). We have observed that this also occurs in developing CG neurons. These experiments focused on the MAP kinase Erk, which becomes active after phosphorylation of two residues by the dual-specific MAP kinase kinase MEK1 (Matsuda et al., 1992; Seger et al., 1992). Dissociated E9 CG neurons were treated with 1 nM TGFbeta 1 or normal medium, and the relative abundance of total Erk and Erk-P2 was determined by immunoblot analysis. Note that chicks differ from mammals in that they express only one form of Erk, and therefore immunoblot analysis reveals only a single 42-43 kDa band for this kinase (Perron and Bixby, 1999; Sanada et al., 2000). Treatment with TGFbeta 1 caused a significant increase in the Erk-P2/total Erk ratio (Fig. 4). Interestingly Erk phosphorylation was relatively transient; increases were detectable within 5 min after the onset of TGFbeta 1 treatment and maintained for at least 1 hr, but returned to baseline after 3 hr, even when TGFbeta 1 was present continuously. The increase in Erk phosphorylation evoked by TGFbeta 1 was completely blocked in CG neurons pretreated with the selective MEK1 inhibitor PD98059 (50 µM), an agent widely used in the study of MAP kinase-signaling cascades (Alessi et al., 1995; Dudley et al., 1995). PD98059 also caused a decrease in basal Erk phosphorylation in CG neurons that were not treated with TGFbeta 1 (Fig. 5).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 4.   TGFbeta 1 evokes a transient activation of Erk MAP kinase in CG neurons. E9 CG neurons were cultured in the presence of 1 nM TGFbeta 1 for various lengths of time as indicated. After treatment, Erk-P2 and total Erk were determined by immunoblot analysis on duplicate gels. Top, Representative blots. Bottom, Mean Erk-P2/Erk ratios ± SEM obtained from three to six independent experiments. TGFbeta 1 evoked an increase in Erk phosphorylation within 5 min. This increase persisted for >1 hr, but Erk-P2 levels returned to baseline at 3 hr, even in the continuous presence of TGFbeta 1. con, Control.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 5.   TGFbeta 1-evoked Erk activation in CG neurons is blocked by the MEK1 inhibitor PD98059. Erk phosphorylation in E9 CG neurons was determined by immunoblot analysis of cells cultured in the presence or absence of PD98059 (50 µM) and/or TGFbeta 1 (1 nM). Top, A representative immunoblot. Bottom, Summary of the mean ± SEM from three independent experiments. Note that PD98059 completely blocked Erk phosphorylation induced by TGFbeta 1 and also caused a marked fall in basal Erk phosphorylation.

These results raise the possibility that TGFbeta 1 acts via MAP kinase cascades to regulate the functional expression of KCa channels. To test this hypothesis, the effects of 1 nM TGFbeta 1 were examined in E9 CG neurons cultured in the presence or absence of 50 µM PD98059. Cells were incubated with this inhibitor beginning 30 min before the addition of trophic factors. In initial experiments, KCa expression was monitored by whole-cell recording 12 hr after the start of TGFbeta 1 treatment (Fig. 6A). As expected, treatment with TGFbeta 1 evoked a robust increase in macroscopic KCa compared with that in controls cultured in the absence of trophic factor. These increases were completely blocked in CG neurons pretreated with PD98059, and KCa expression in those cells was indistinguishable from that in controls. PD98059 also blocked the KCa stimulatory effects of iris extracts (data not shown). Treatment with PD98059 by itself had no effect on KCa expression. These results are statistically significant (p < 0.05). We have shown previously that KCa density is maximal in CG neurons by E13 (Dourado and Dryer, 1992; Cameron et al., 1998, 1999), and it is worth noting that 50 µM PD98059 had no effect on whole-cell KCa in CG neurons isolated at that stage (data not shown). Therefore, the effects of PD98059 cannot be attributed to direct blockade of KCa channels, a point that can also be ascertained in Figure 7B. Moreover PD98059 had no effect on the expression or gating of voltage-activated Ca2+ currents in E9 CG neurons growing either in the presence or absence of trophic factors (data not shown). PD98059 has been reported to inhibit increases in CaM kinase II associated with the induction of long-term potentiation in CA1 hippocampal neurons (Liu et al., 1999). Therefore, to exclude the possibility that PD98059 actions were caused by inhibition of CaM kinase II, E9 CG neurons were treated with the CaM kinase II inhibitor KN-62 (10 µM). This drug had no effect on the stimulation of KCa evoked by TGFbeta 1 in CG neurons (Fig. 6B). In summary, these data strongly suggest that signaling via Erk is required for the acute stimulation of the KCa expression evoked by TGFbeta 1.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 6.   Inhibition of Erk signaling blocks the stimulatory effects of TGFbeta 1 on KCa expression in CG neurons. E9 CG neurons were cultured for 12 hr in medium containing 1 nM TGFbeta 1 in the presence or absence of protein kinase inhibitors. Cells were incubated with these inhibitors beginning 30 min before the addition of trophic factors. KCa was measured by whole-cell recording at the end of the 12 hr trophic factor treatment. Numbers in parentheses indicate the number of cells recorded for each condition. A, The MEK1 inhibitor PD98059 (50 µM) completely blocked stimulation of KCa expression evoked by a 12 hr treatment with 1 nM TGFbeta 1. B, The CaM kinase II inhibitor KN-62 (10 µM) had no effect on TGFbeta 1-stimulated KCa expression. Asterisks denote p < 0.05 compared with control cells, and n.s. denotes no significant difference. Data were analyzed by one-way ANOVA followed by Scheffé's post hoc test.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 7.   Acute and sustained effects of TGFbeta 1 on KCa expression in CG neurons require early Erk activation. E9 CG neurons were cultured for 12 hr in a medium containing no trophic factor (open circle ), 1 nM TGFbeta 1 (), or a combination of 1 nM TGFbeta 1 and 50 µM PD98059 (black-square). A, Application of PD98059 (filled horizontal bar) during and after exposure to TGFbeta 1 (hatched horizontal bar) blocked both the acute and sustained stimulatory effects of TGFbeta 1 on KCa expression. B, In contrast, application of PD98059 starting after cessation of the 12 hr TGFbeta 1 treatment had no effect on the sustained stimulation of KCa. Therefore, both the acute and long-lasting stimulatory effects of TGFbeta 1 require transient activation of Erk, and PD98059 does not cause direct blockade of KCa.

Is Erk activation also required for the sustained stimulation of KCa evoked by TGFbeta 1? In these experiments, the effects of 1 nM TGFbeta 1 were examined in neurons cultured in the presence or absence of 50 µM PD98059. An additional group of control neurons was cultured in the absence of trophic factor (Fig. 7). Both the acute and sustained effects of TGFbeta 1 on KCa expression were blocked by PD98059 when it was present during the 12 hr TGFbeta 1 treatment (and for the next 3.5 d thereafter). These results are statistically significant (p < 0.05) and suggest that MAP kinase signaling is required for both components of TGFbeta 1 action (Fig. 7A). However PD98059 had no effect on either acute or sustained stimulation of KCa when it was applied immediately after cessation of the 12 hr TGFbeta 1 treatment (Fig. 7B). This result is consistent with the immunoblot analyses indicating that TGFbeta 1-induced Erk phosphorylation returns to baseline after 3 hr of continuous treatment (Fig. 5). Therefore, activation of Erk MAP kinase during the first 12 hr of treatment is essential for the induction of KCa stimulation, but ongoing activation of this pathway is not required for the sustained effects of TGFbeta 1.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Previous studies from our laboratory have shown that an avian ortholog of TGFbeta 1, known as TGFbeta 4, is essential for the developmental expression of functional plasma membrane KCa channels in chick ciliary neurons (Subramony et al., 1996; Cameron et al., 1998, 1999; Lhuillier and Dryer, 1999). In the present study we have shown that TGFbeta 1 has a biphasic action comprised of an acute stimulation of KCa expression mediated by posttranslational processes and a sustained effect that requires the transcription and synthesis of new proteins. Both effects require activation of the MAP kinase Erk. The sustained effect of TGFbeta 1 suggests that continued exposure to this trophic factor may not be required for the maintenance of functional KCa channels in vivo. In this regard, TGFbeta 4 transcripts are detectable in the chick eye by E9, remain robust until E12, but subsequently decline to substantially lower levels by the time of hatching (Jakowlew et al., 1992).

The precise mechanism of the TGFbeta 1-evoked posttranslational stimulation of KCa could entail covalent modification of channels that are already in the plasma membrane, modification of other proteins that interact with KCa channels, recruitment of KCa channels into the plasma membrane, or some combination of these processes. Maximal stimulation of macroscopic KCa does not occur until 5-7 hr after the onset of TGFbeta 1 treatment, and TGFbeta 1 needs to be present for 1 hr to observe maximal acute stimulation of KCa. This time course is faster than that of neuromodulation events that entail direct phosphorylation or dephosphorylation of channel molecules. This raises the possibility that translocation of some membrane protein, possibly the SLO alpha  subunits themselves, is required. We have obtained preliminary evidence that supports this theory; specifically we have found that application of microtubule-disrupting agents such as colchicine can block the acute KCa stimulatory effects of TGFbeta 1 (L. Lhuillier and S. E. Dryer, unpublished data). In addition, Xia et al. (1998) and Schopperle et al. (1998) have identified two proteins, known as Slob and dSLIP-1, that interact with the SLO channels of Drosophila. Coexpression of either of these proteins with SLO channels in heterologous systems prevents translocation of SLO channels to the plasma membrane and thereby results in SLO accumulation in intracellular pools. It is possible that TGFbeta 1 regulates the plasma membrane targeting of chick ciliary neuron SLO channels by modulating their interaction with molecules that have a similar mode of action. Because of this, it also is worth noting that TGFbeta 1 does not induce a detectable increase in the expression of slo transcripts in E9 CG neurons, even though transcription and translation at approximately the time of TGFbeta 1 treatment are required for the sustained stimulation of KCa. This suggests that the synthesis of other proteins is required for the sustained TGFbeta 1-evoked stimulation of functional KCa channels, possibly proteins required for normal processing or trafficking of these channels.

A number of previous studies have shown that the duration of Erk activation has profound consequences on subsequent cellular responses (for review, see Widmann et al., 1999). For example, in most pheochromocytoma 12 (PC12) cell lines, transient Erk activation [evoked by epidermal growth factor (EGF)] results in cell proliferation, whereas sustained Erk activation (evoked by NGF) causes these cells to leave the cell cycle and differentiate toward a neuronal phenotype (Traverse et al., 1992; Yaka et al., 1998; York et al., 1998). Moreover EGF does cause neuronal differentiation in certain PC12 cell lines in which EGF evokes abnormally sustained Erk activation (Traverse et al., 1994; Yamada et al., 1996). Here we have observed that TGFbeta 1 evokes an almost immediate but transient stimulation of Erk phosphorylation in developing CG neurons. Maximal sustained KCa stimulation requires 3 hr of continuous exposure to TGFbeta 1, even though Erk activation has returned to baseline levels by that time. This suggests that Erk activation is a relatively early event in the cascades that lead to either acute or sustained stimulation of KCa expression. Activated Erk can phosphorylate a host of cytosolic and nuclear target molecules and thereby initiate a variety of intracellular events, including transcriptional activation and modulation of other signal transduction cascades (Widmann et al., 1999). In some cells this can take the form of a negative feedback loop, because activated Erk can directly inhibit molecules, such as ras and MEK1, that are required for its own activation (Whitmarsh and Davis, 1996). Our data on the timing of TGFbeta 1 receptor stimulation and Erk phosphorylation are consistent with a model in which TGFbeta 1 activates multiple signaling cascades, including pathways that feed back to limit the duration of Erk activation, along with separate sustained cascades involved in transcriptional control.

Many of the actions of TGFbeta s and related factors are mediated by a family of intracellular transduction proteins known as SMADs (Baker and Harland, 1997; Heldin et al., 1997; Massague, 1998). SMADs are transcription factors that are translocated to the nucleus as heteromeric complexes after the activation of TGFbeta receptors. These molecules have distinct trans-activation and/or protein interaction domains but do not have any other (known) enzymatic activities or sequence motifs that would suggest additional activities (Kawabata and Miyazono, 1999). Therefore, a mechanism by which SMADs could mediate the acute posttranslational effects of TGFbeta 1 is not obvious from the current literature. However SMADs could well be involved in the sustained effects of TGFbeta 1, even though Erk activation is required for this effect. For example, it is possible that sustained stimulation of KCa requires the binding of SMADs and Erk-sensitive transcription factors to the cis-acting regulatory elements of a single gene (but probably not the slo gene). In this regard, the formation of complexes between Smad2/4 and an Erk-sensitive basic leucine zipper transcription factor is required for transcriptional activation by TGFbeta in vascular endothelial cells (Topper et al., 1998). Alternatively, sustained stimulation of KCa may require transcriptional activation of multiple genes that are regulated independently by SMADs and Erk-sensitive transcription factors. Finally, it is possible that Erk causes direct phosphorylation of SMAD-containing complexes. This occurs in intestinal epithelial cells, in which Erk-dependent phosphorylation of Smad1 appears to be essential for TGFbeta 1-induced transcriptional activation (Yue et al., 1999).

It is worth noting that other members of the TGFbeta superfamily of growth factors produce effects on developing CG neurons. For example, activin induces expression of somatostatin immunoreactivity in CG neurons. During normal in vivo development, secretion of follistatin from the iris ensures that only those CG neurons that innervate the choroid layer are normally exposed to this factor (Darland et al., 1995; Darland and Nishi, 1998), but all CG neurons are competent to respond to activin (Coulombe et al., 1993). In agreement with these observations, type IIA activin receptors are expressed in CG neurons (Kos and Coulombe, 1997). In addition, we have observed that target-derived TGFbeta 3 causes inhibition of KCa stimulation evoked by either TGFbeta 1 or beta -neuregulin-1 and that this effect is physiologically significant for the normal in vivo expression of these channels in ciliary neurons (Cameron et al., 1999). The inhibitory effect of TGFbeta 3 is not caused by competitive inhibition with TGFbeta 1 for a common pool of receptors. These observations suggest that several potentially SMAD-dependent pathways control the differentiation of CG neurons. It is possible that activation of additional pathways, such as the Erk MAP kinase pathway, by one or more of these factors provides an additional measure of specificity in signaling. In other words, the sum total of transduction pathways activated by a given trophic factor may be the key parameter that determines the final response, and therefore different factors that cause activation of a common signaling molecule may evoke very different responses.

In summary, we have observed that TGFbeta 1 evokes an acute posttranslational stimulation of functional KCa channels in chick ciliary neurons, along with a more sustained effect that requires the transcription and synthesis of new proteins. Both of these effects are associated with transient activation of Erk MAP kinase. Activation of Erk may be a common feature of the actions of TGFbeta s and related growth factors on neuronal cells.


    FOOTNOTES

Received March 21, 2000; revised May 2, 2000; accepted May 9, 2000.

This work was supported by National Institutes of Health Grant NS-32748. We are grateful to Patrick Callaerts and Claudio Punzo for assistance with immunoblot analysis, Laurence Dryer for reading previous drafts of this manuscript and assistance with RT-PCR, and Jill Cameron for helpful discussions.

Correspondence should be addressed to Dr. Stuart E. Dryer at the above address. E-mail: SDryer{at}UH.EDU.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995) PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494[Abstract/Free Full Text].
  • Baker JC, Harland RM (1997) From receptor to nucleus: the Smad pathway. Curr Opin Genet Dev 7:467-473[Web of Science][Medline].
  • Bruses JL, Pilar GR (1995) Effect of cycloheximide and mRNA synthesis inhibition on death of trophically deprived ciliary ganglion neurons in culture. J Neurophysiol 74:2487-2499[Abstract/Free Full Text].
  • Burt DW, Paton IR (1992) Evolutionary origins of the transforming growth factor-beta gene family. DNA Cell Biol 11:497-510[Web of Science][Medline].
  • Cameron JS, Lhuillier L, Subramony P, Dryer SE (1998) Developmental regulation of neuronal K+ channels by target-derived TGFbeta in vivo and in vitro. Neuron 21:1045-1053[Web of Science][Medline].
  • Cameron JS, Dryer L, Dryer SE (1999) Regulation of neuronal K+ currents by target-derived factors: opposing actions of two different isoforms of TGFbeta . Development 126:4157-4164[Abstract].
  • Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159[Web of Science][Medline].
  • Coulombe JN, Schwall R, Parent AS, Eckenstein FP, Nishi R (1993) Induction of somatostatin immunoreactivity in cultured ciliary ganglion neurons by activin in choroid cell-conditioned medium. Neuron 10:899-906[Web of Science][Medline].
  • Darland DC, Nishi R (1998) Activin A and follistatin influence expression of somatostatin in the ciliary ganglion in vivo. Dev Biol 202:293-303[Web of Science][Medline].
  • Darland DC, Link BA, Nishi R (1995) Activin A and follistatin expression in developing targets of ciliary ganglion neurons suggests a role in regulating neurotransmitter phenotype. Neuron 15:857-866[Web of Science][Medline].
  • Dourado MM, Dryer SE (1992) Changes in the electrical properties of chick ciliary ganglion neurones during embryonic development. J Physiol (Lond) 449:411-428[Abstract/Free Full Text].
  • Dourado MM, Brumwell C, Wisgirda ME, Jacob MH, Dryer SE (1994) Target tissues and innervation regulate the characteristics of K+ currents in chick ciliary ganglion neurons developing in situ. J Neurosci 14:3156-3165[Abstract].
  • Dryer SE (1998) Role of cell-cell interactions in the developmental regulation of Ca2+-activated K+ currents in vertebrate neurons. J Neurobiol 37:23-36[Web of Science][Medline].
  • Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689[Abstract/Free Full Text].
  • Hartsough MT, Mulder KM (1995) Transforming growth factor-beta activation of p44 MAPK in proliferating cultures of epithelial cells. J Biol Chem 270:7117-7124[Abstract/Free Full Text].
  • Hartsough MT, Frey RS, Zipfel PA, Buard A, Cook SJ, McCormick F, Mulder KM (1996) Altered transforming growth factor signaling in epithelial cells when ras activation is blocked. J Biol Chem 271:22368-22375[Abstract/Free Full Text].
  • Heldin CH, Miyazono K, ten Dijke P (1997) TGFbeta signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471[Medline].
  • Jakowlew SB, Ciment G, Tuan RS, Sporn MB, Roberts AB (1992) Pattern of expression of transforming growth factor-beta 4 mRNA and protein in the developing chicken embryo. Dev Dyn 195:276-289[Web of Science][Medline].
  • Johnson K, Kirkpatrick H, Comer A, Hoffmann FM, Laughon A (1999) Interaction of Smad complexes with tripartite DNA-binding sites. J Biol Chem 274:20709-20716[Abstract/Free Full Text].
  • Kawabata M, Miyazono K (1999) Signal transduction of the TGFbeta superfamily by Smad proteins. J Biochem (Tokyo) 125:9-16[Abstract/Free Full Text].
  • Kos K, Coulombe JN (1997) Activin receptor mRNA expression by neurons of the avian ciliary ganglion. J Neurobiol 32:33-44[Web of Science][Medline].
  • Kretzschmar M, Massague J (1998) SMADs: mediators and regulators of TGFbeta signaling. Curr Opin Genet Dev 8:103-111[Web of Science][Medline].
  • Lhuillier L, Dryer SE (1999) TGFbeta 1 regulates the gating properties of intermediate-conductance KCa channels in developing parasympathetic neurons. J Neurophysiol 82:1627-1631[Abstract/Free Full Text].
  • Liu J, Fukunaga K, Yamamoto H, Nishi K, Miyamoto E (1999) Differential roles of Ca2+/calmodulin-dependent protein kinase II and mitogen-activated protein kinase activation in hippocampal long-term potentiation. J Neurosci 19:8292-8299[Abstract/Free Full Text].
  • Massague J (1998) TGFbeta signal transduction. Annu Rev Biochem 67:753-791[Web of Science][Medline].
  • Matsuda S, Kosako H, Takenaka K, Moriyama K, Sakai H, Akiyama T, Gotoh Y, Nishida E (1992) Xenopus MAP-kinase activator: identification and function of a key intermediate in the phosphorylation cascade. EMBO J 11:973-982[Web of Science][Medline].
  • Perron JC, Bixby JL (1999) Distinct neurite outgrowth signaling pathways converge on Erk activation. Mol Cell Neurosci 13:362-378[Web of Science][Medline].
  • Sanada K, Hayashi Y, Harada Y, Okano T, Fukada Y (2000) Role of circadian activation of mitogen-activated protein kinase in chick pineal clock oscillation. J Neurosci 20:986-991[Abstract/Free Full Text].
  • Schopperle WM, Holmqvist MH, Zhou Y, Wang J, Wang Z, Griffith LC, Keselman I, Kusinitz F, Dagan D, Levitan IB (1998) Slob, a novel protein that interacts with the Slowpoke calcium-dependent potassium channel. Neuron 20:565-573[Web of Science][Medline].
  • Seger R, Ahn NG, Posada J, Munar ES, Jensen AM, Cooper JA, Cobb MH, Krebs EG (1992) Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. J Biol Chem 267:14373-14381[Abstract/Free Full Text].
  • Shioda T, Lechleider RJ, Dunwoodie SL, Li H, Yahata T, de Caestecker MP, Fenner MH, Roberts AB, Isselbacher KJ (1998) Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci USA 95:9785-9790[Abstract/Free Full Text].
  • Subramony P, Raucher S, Dryer L, Dryer SE (1996) Posttranslational regulation of Ca2+-activated K+ currents by a target-derived factor in developing parasympathetic neurons. Neuron 17:115-124[Web of Science][Medline].
  • Tkatch T, Baranauskas G, Surmeier DJ (2000) Kv4.2 mRNA abundance and A-type K+ current amplitude are linearly related in basal ganglia and basal forebrain neurons. J Neurosci 20:579-588[Abstract/Free Full Text].
  • Topper JN, DiChiara MR, Brown JD, Williams AJ, Falb D, Collins T, Gimbrone Jr MA (1998) CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor-beta transcriptional responses in endothelial cells. Proc Natl Acad Sci USA 95:9506-9511[Abstract/Free Full Text].
  • Traverse S, Gomez N, Paterson H, Marshall CJ, Cohen P (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells: comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 288:351-355.
  • Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A (1994) EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 4:694-701[Web of Science][Medline].
  • Whitmarsh AJ, Davis RJ (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607[Web of Science][Medline].
  • Widmann C, Gibson S, Jarpe MB, Johnson GL (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180[Abstract/Free Full Text].
  • Xia XM, Hirschberg B, Smolik S, Forte M, Adelman JP (1998) dSLo interacting protein 1, a novel protein that interacts with large-conductance calcium-activated potassium channels. J Neurosci 18:2360-2369[Abstract/Free Full Text].
  • Yaka R, Gamliel A, Gurwitz D, Stein R (1998) NGF induces transient but not sustained activation of Erk in PC12 mutant cells incapable of differentiating. J Cell Biochem 70:425-432[Web of Science][Medline].
  • Yamada M, Ikeuchi T, Aimoto S, Hatanaka H (1996) PC12h-R cell, a subclone of PC12 cells, shows EGF-induced neuronal differentiation and sustained signaling. J Neurosci Res 43:355-364[Web of Science][Medline].
  • York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJ (1998) Rap1 mediates sustained MAP-kinase activation induced by nerve growth factor. Nature 392:622-626[Medline].
  • Yue J, Frey RS, Mulder KM (1999) Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta . Oncogene 18:2033-2037[Web of Science][Medline].


Copyright © 2000 Society for Neuroscience  0270-6474/00/20155616-07$05.00/0


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
L. D. Ridgway, E. Y. Kim, and S. E. Dryer
MAGI-1 interacts with Slo1 channel proteins and suppresses Slo1 expression on the cell surface
Am J Physiol Cell Physiol, July 1, 2009; 297(1): C55 - C65.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
E. Y. Kim, S. Zou, L. D. Ridgway, and S. E. Dryer
beta1-Subunits Increase Surface Expression of a Large-Conductance Ca2+-Activated K+ Channel Isoform
J Neurophysiol, May 1, 2007; 97(5): 3508 - 3516.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. Chin, R.-Y. Liu, L. J. Cleary, A. Eskin, and J. H. Byrne
TGF-beta1-Induced Long-Term Changes in Neuronal Excitability in Aplysia Sensory Neurons Depend on MAPK
J Neurophysiol, May 1, 2006; 95(5): 3286 - 3290.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
M. R. Keyser and J. L. Witten
Calcium-activated potassium channel of the tobacco hornworm, Manduca sexta: molecular characterization and expression analysis
J. Exp. Biol., November 1, 2005; 208(21): 4167 - 4179.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K.-S. Chae, K.-S. Oh, and S. E. Dryer
Growth Factors Mobilize Multiple Pools of KCa Channels in Developing Parasympathetic Neurons: Role of ADP-Ribosylation Factors and Related Proteins
J Neurophysiol, August 1, 2005; 94(2): 1597 - 1605.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K.-S. Chae, M. Martin-Caraballo, M. Anderson, and S. E. Dryer
Akt Activation Is Necessary for Growth Factor-Induced Trafficking of Functional KCa Channels in Developing Parasympathetic Neurons
J Neurophysiol, March 1, 2005; 93(3): 1174 - 1182.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Martin-Caraballo and S. E. Dryer
Glial Cell Line-Derived Neurotrophic Factor and Target-Dependent Regulation of Large-Conductance KCa Channels in Developing Chick Lumbar Motoneurons
J. Neurosci., December 1, 2002; 22(23): 10201 - 10208.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. Lhuillier and S. E. Dryer
Developmental Regulation of Neuronal KCa Channels by TGFbeta 1: An Essential Role for PI3 Kinase Signaling and Membrane Insertion
J Neurophysiol, August 1, 2002; 88(2): 954 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Zhu, G.-Y. Yang, B. Ahlemeyer, L. Pang, X.-M. Che, C. Culmsee, S. Klumpp, and J. Krieglstein
Transforming Growth Factor-beta 1 Increases Bad Phosphorylation and Protects Neurons Against Damage
J. Neurosci., May 15, 2002; 22(10): 3898 - 3909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. Kifor, R. J. MacLeod, R. Diaz, M. Bai, T. Yamaguchi, T. Yao, I. Kifor, and E. M. Brown
Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells
Am J Physiol Renal Physiol, February 1, 2001; 280(2): F291 - F302.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Cameron, L. Dryer, and S. E. Dryer
beta -Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons
PNAS, February 1, 2001; (2001) 41394098.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
J. S. Cameron and S. E. Dryer
BK-Type KCa Channels in Two Parasympathetic Cell Types: Differences in Kinetic Properties and Developmental Expression
J Neurophysiol, December 1, 2000; 84(6): 2767 - 2776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. R. Perillan, M. Chen, E. A. Potts, and J. M. Simard
Transforming Growth Factor-beta 1 Regulates Kir2.3 Inward Rectifier K+ Channels via Phospholipase C and Protein Kinase C-delta in Reactive Astrocytes from Adult Rat Brain
J. Biol. Chem., January 11, 2002; 277(3): 1974 - 1980.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Cameron, L. Dryer, and S. E. Dryer
beta -Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons
PNAS, February 27, 2001; 98(5): 2832 - 2836.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lhuillier, L.
Right arrow Articles by Dryer, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lhuillier, L.
Right arrow Articles by Dryer, S. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-